Mucormycosis risk factors: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Mucormycosis}} {{CMG}}; {{AE}}{{HK}} ==Overview== ==Risk factors== The following conditions predispose patients to mucormycosis: * Immunodeficient states ** T...") |
No edit summary |
||
| Line 12: | Line 12: | ||
** Diabetes (including diabetic ketoacidosis) | ** Diabetes (including diabetic ketoacidosis) | ||
** AIDS | ** AIDS | ||
** Severe lymphocytopenia | |||
** Malignancy | |||
* Dialysis patients on Iron chelation therapy (deferoxamine) | * Dialysis patients on Iron chelation therapy (deferoxamine) | ||
{{WH}}{{WS}} | |||
{{reflist|2}} | |||
Revision as of 21:52, 24 May 2017
|
Mucormycosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Risk factors
The following conditions predispose patients to mucormycosis:
- Immunodeficient states
- Transplant recepients
- Diabetes (including diabetic ketoacidosis)
- AIDS
- Severe lymphocytopenia
- Malignancy
- Dialysis patients on Iron chelation therapy (deferoxamine)